Funds and ETFs Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
42.34 USD +0.19% Intraday chart for Taro Pharmaceutical Industries Ltd. +0.36% +1.34%

ETFs positioned on Taro Pharmaceutical Industries Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 10 M€ -3.35% -
0.00% 7 M€ +4.29% -
0.00% 36 M€ +4.92% -
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
42.34 USD
Average target price
43 USD
Spread / Average Target
+1.56%
Consensus
  1. Stock
  2. Equities
  3. Stock Taro Pharmaceutical Industries Ltd. - Nyse
  4. Funds and ETFs Taro Pharmaceutical Industries Ltd.